Clinical Trials Sponsored by Covance Harrogate
Total 249 results
-
GlaxoSmithKlineHammersmith Medicines Research; Covance HarrogateCompletedHypertension, PulmonaryUnited Kingdom
-
EnteromeCovanceActive, not recruitingGlioblastoma, AdultUnited States, Spain, France, Germany
-
CelgeneCovanceCompletedHealthyUnited States
-
AffibodyCovanceCompletedPsoriasis | Healthy SubjectsUnited Kingdom
-
Wellmarker BioCovanceRecruitingHead and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Cholangiocarcinoma | Advanced Solid Tumor | Metastatic Solid TumorKorea, Republic of, Australia
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
CTI BioPharmaCovanceCompleted
-
X4 PharmaceuticalsCovanceTerminatedHealthyUnited States
-
Neomed InstituteCovanceCompleted
-
BioVex LimitedCovanceCompleted
-
Anesiva, Inc.CovanceTerminatedIntravenous Placement Procedure
-
GE HealthcareCovanceRecruitingMyocardial Ischemia | Coronary Artery DiseaseFrance, Greece, Italy, United Kingdom
-
KBP BiosciencesCovanceCompletedHealthy | Drug Drug InteractionUnited States
-
KBP BiosciencesCovanceCompletedHealthyUnited States
-
KBP BiosciencesCovanceCompletedHealthy | Moderate Hepatic ImpairmentUnited States
-
CTI BioPharmaCovanceCompleted
-
Anji PharmaCovanceCompletedFunctional ConstipationChina, United States
-
Algenis SpACovanceCompleted
-
VIVUS LLCCovanceCompleted
-
Sardocor Corp.CovanceRecruitingHeart Failure | Congestive Heart Failure | Heart Failure, Systolic | HFrEF - Heart Failure With Reduced Ejection FractionUnited States
-
HiberCell, Inc.CovanceCompletedRenal Cell Carcinoma | Gastric Cancer | Metastatic Breast Cancer | Small-cell Lung Cancer | Other Solid TumorsUnited States
-
KBP BiosciencesCovanceCompleted
-
CTI BioPharmaCovanceCompletedHealthy SubjectsUnited States
-
CTI BioPharmaCovanceCompleted
-
AnaMar ABCovanceCompletedTolerability | SafetyUnited Kingdom
-
Adaptive BiotechnologiesCovanceCompleted
-
Adaptive BiotechnologiesCovanceCompleted
-
Spero TherapeuticsCovanceCompleted
-
Aeromics, Inc.CovanceCompleted
-
CTI BioPharmaCovanceCompletedDrug Interaction StudyUnited States
-
AnaMar ABCovanceCompletedAtopic DermatitisUnited Kingdom
-
Medical University of GrazNeoss Ltd., Harrogate, UKCompletedEdentulous JawAustria
-
Impact Therapeutics, Inc.CovanceRecruitingAdvanced Solid TumorsUnited States, Taiwan, China
-
Golden Biotechnology CorporationCovanceActive, not recruitingPancreatic NeoplasmUnited States, Korea, Republic of, Taiwan
-
Emalex Biosciences Inc.CovanceCompletedHealthy VolunteerUnited Kingdom
-
Matinas Biopharma, IncCovanceWithdrawn
-
Galecto Biotech ABCovanceWithdrawn
-
RAI Services CompanyCovanceCompleted
-
Erasmus Medical CenterCovanceCompletedCardiovascular DiseasesSpain, Netherlands, Italy, Switzerland
-
Volta MedicalCovance; CardiaBaseCompletedAtrial FibrillationUnited States, Germany, Belgium, France, Netherlands
-
Aptabio Therapeutics, Inc.CovanceTerminated
-
Bridge Biotherapeutics, Inc.CovanceCompletedUlcerative ColitisUnited States, Korea, Republic of, Poland, Ukraine
-
Anthos Therapeutics, Inc.CovanceCompletedAtrial FibrillationUnited States
-
Bridge Biotherapeutics, Inc.CovanceTerminatedUlcerative ColitisNew Zealand
-
Hua Medicine LimitedCovanceCompletedDiabetes Mellitus, Type 2China
-
Heptares Therapeutics LimitedCovanceCompleted
-
F2G Biotech GmbHCovanceCompleted
-
PegBio Co., Ltd.CovanceCompletedType 2 Diabetes Mellitus (T2DM)United States
-
Bristol-Myers SquibbCovanceCompletedPsoriasisUnited States
-
VIVUS LLCCovance; SentrxCompletedHepatic ImpairmentUnited States